Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Urothelial Cancer × cabozantinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 6 Multiple Myeloma 2 Carcinoma, Hepatocellular 2 Urothelial Cancer 1 Urologic Neoplasms 1 Recurrence 1 Prostatic Neoplasms 1 Neuroendocrine Tumors 1 Kidney Neoplasms 1 Kidney Diseases 1 Gliosarcoma 1 Glioblastoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1

Interventions

niraparib 1 durvalumab 1 cabozantinib 1 Radiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03425201 2024-12-31

NICARAGUA

Fundacion CRIS de Investigación para Vencer el Cáncer

Phase 1/2 Completed

Urothelial Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡